Predicting the outcome of peptide receptor radionuclide therapy in neuroendocrine tumors: the importance of dual-tracer imaging
Crossref DOI link: https://doi.org/10.1007/s00259-017-3667-7
Published Online: 2017-03-10
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zanotti-Fregonara, Paolo
Morgat, Clément
Champion, Christophe
Hindié, Elif
License valid from 2017-03-10